Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Bacterial keratitis: Photodynamic inactivation reduced experimental inflammation.

Deichelbohrer M, Wu MF, Seitz B, Hüttenberger D, Laschke MW, Foth HJ, Wonnenberg B, Wagenpfeil S, Meier C, Bischoff M, Tschernig T.

Exp Ther Med. 2017 Nov;14(5):4509-4514. doi: 10.3892/etm.2017.5109. Epub 2017 Sep 5.

2.

Chlorin e6 mediated photodynamic inactivation for multidrug resistant Pseudomonas aeruginosa keratitis in mice in vivo.

Wu MF, Deichelbohrer M, Tschernig T, Laschke MW, Szentmáry N, Hüttenberger D, Foth HJ, Seitz B, Bischoff M.

Sci Rep. 2017 Mar 15;7:44537. doi: 10.1038/srep44537.

3.

Photodynamic inactivation of multidrug-resistant Staphylococcus aureus by chlorin e6 and red light (λ=670nm).

Winkler K, Simon C, Finke M, Bleses K, Birke M, Szentmáry N, Hüttenberger D, Eppig T, Stachon T, Langenbucher A, Foth HJ, Herrmann M, Seitz B, Bischoff M.

J Photochem Photobiol B. 2016 Sep;162:340-347. doi: 10.1016/j.jphotobiol.2016.07.007. Epub 2016 Jul 9.

PMID:
27419618
4.

High exposure to inorganic arsenic by food: the need for risk reduction.

Gundert-Remy U, Damm G, Foth H, Freyberger A, Gebel T, Golka K, Röhl C, Schupp T, Wollin KM, Hengstler JG.

Arch Toxicol. 2015 Dec;89(12):2219-27. doi: 10.1007/s00204-015-1627-1. Epub 2015 Nov 19. Review.

PMID:
26586021
5.

In vitro studies of different irradiation conditions for Photodynamic inactivation of Helicobacter pylori.

Simon C, Mohrbacher C, Hüttenberger D, Bauer-Marschall I, Krickhahn C, Stachon A, Foth HJ.

J Photochem Photobiol B. 2014 Dec;141:113-8. doi: 10.1016/j.jphotobiol.2014.09.015. Epub 2014 Oct 12.

PMID:
25463658
6.

Manufactured nanomaterials: categorization and approaches to hazard assessment.

Gebel T, Foth H, Damm G, Freyberger A, Kramer PJ, Lilienblum W, Röhl C, Schupp T, Weiss C, Wollin KM, Hengstler JG.

Arch Toxicol. 2014 Dec;88(12):2191-211. doi: 10.1007/s00204-014-1383-7. Epub 2014 Oct 19. Review.

PMID:
25326817
7.

Safety of nanomaterials.

Foth H, Stewart JD, Gebel T, Bolt HM.

Arch Toxicol. 2012 Jul;86(7):983-4. doi: 10.1007/s00204-012-0889-0. No abstract available.

PMID:
22733142
8.

Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

Hengstler JG, Foth H, Gebel T, Kramer PJ, Lilienblum W, Schweinfurth H, Völkel W, Wollin KM, Gundert-Remy U.

Crit Rev Toxicol. 2011 Apr;41(4):263-91. doi: 10.3109/10408444.2011.558487. Review.

9.

PARP-1 expression and activity in primary human lung cells.

Ahmad M, Torky A, Glahn F, Scheubel RJ, Foth H.

Arch Toxicol. 2011 Jun;85(6):669-79. doi: 10.1007/s00204-010-0604-y. Epub 2010 Oct 16.

PMID:
20953586
10.

Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis.

Bruce-Micah R, Hüttenberger D, Freitag L, Cullum J, Foth HJ.

J Photochem Photobiol B. 2009 Oct 6;97(1):1-7. doi: 10.1016/j.jphotobiol.2009.07.004. Epub 2009 Jul 8.

PMID:
19648025
11.

Autofluorescence detection of tumors in the human lung--spectroscopical measurements in situ, in an in vivo model and in vitro.

Hüttenberger D, Gabrecht T, Wagnières G, Weber B, Linder A, Foth HJ, Freitag L.

Photodiagnosis Photodyn Ther. 2008 Jun;5(2):139-47. doi: 10.1016/j.pdpdt.2008.05.002. Epub 2008 Jun 26.

PMID:
19356645
12.

[Responsibilities of the European Chemical Agency under REACH].

Foth H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Dec;51(12):1398-407. doi: 10.1007/s00103-008-0713-4. Review. German.

PMID:
19137215
13.

[Risk assessment and chemical safety under REACH].

Foth H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Dec;51(12):1387-97. doi: 10.1007/s00103-008-0712-5. Review. German.

PMID:
19137214
14.

[REACH--an ambitious project on the path to chemical safety].

Foth H, Kahl R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Dec;51(12):1379-80. doi: 10.1007/s00103-008-0727-y. German. No abstract available.

PMID:
19137212
15.

Background of REACH in EU regulations on evaluation of chemicals.

Foth H, Hayes A.

Hum Exp Toxicol. 2008 Jun;27(6):443-61. doi: 10.1177/0960327108092296.

PMID:
18784197
16.

Cadmium, cobalt and lead cause stress response, cell cycle deregulation and increased steroid as well as xenobiotic metabolism in primary normal human bronchial epithelial cells which is coordinated by at least nine transcription factors.

Glahn F, Schmidt-Heck W, Zellmer S, Guthke R, Wiese J, Golka K, Hergenröder R, Degen GH, Lehmann T, Hermes M, Schormann W, Brulport M, Bauer A, Bedawy E, Gebhardt R, Hengstler JG, Foth H.

Arch Toxicol. 2008 Aug;82(8):513-24. doi: 10.1007/s00204-008-0331-9. Epub 2008 Jul 25.

PMID:
18654764
17.

Concept of REACH and impact on evaluation of chemicals.

Foth H, Hayes A.

Hum Exp Toxicol. 2008 Jan;27(1):5-21. doi: 10.1177/0960327107087801. Review.

PMID:
18480145
18.

Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).

Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.

Arch Toxicol. 2008 Apr;82(4):211-36. doi: 10.1007/s00204-008-0279-9. Epub 2008 Mar 6.

PMID:
18322675
19.

Arachidonic acid pathway activates multidrug resistance related protein in cultured human lung cells.

Torky A, Raemisch A, Glahn F, Foth H.

Arch Toxicol. 2008 May;82(5):323-32. Epub 2007 Oct 18.

PMID:
17943274
20.

Pharmacokinetics of the photosensitizers aminolevulinic acid and aminolevulinic acid hexylester in oro-facial tumors embedded in the chorioallantois membrane of a hen's egg.

Hoppenheit C, Hüttenberger D, Foth HJ, Spitzer WJ, Reichert TE, Müller-Richter UD.

Cancer Biother Radiopharm. 2006 Dec;21(6):569-78.

PMID:
17257072
21.

The REACH concept and its impact on toxicological sciences.

Hengstler JG, Foth H, Kahl R, Kramer PJ, Lilienblum W, Schulz T, Schweinfurth H.

Toxicology. 2006 Mar 15;220(2-3):232-9. No abstract available.

PMID:
16555380
22.

Non-destructive micromethod for MRP1 functional assay in human lung tumor cells.

Stehfest E, Torky A, Glahn F, Foth H.

Arch Toxicol. 2006 Mar;80(3):125-33. Epub 2005 Dec 22.

PMID:
16374597
23.

Expression of lung resistance-related protein, LRP, and multidrug resistance-related protein, MRP1, in normal human lung cells in long-term cultures.

Lehmann T, Torky AR, Stehfest E, Hofmann S, Foth H.

Arch Toxicol. 2005 Oct;79(10):600-9. Epub 2005 Jun 29.

PMID:
15986202
24.

New aspects in the classification of carcinogens.

Foth H, Degen GH, Bolt HM.

Arh Hig Rada Toksikol. 2005 Jun;56(2):167-75. Review.

PMID:
15968833
25.

[Not only eggs from free roaming chickens are contaminated. How dangerous is dioxin in foods?].

Foth H.

MMW Fortschr Med. 2005 Feb 3;147(5):16. German. No abstract available.

PMID:
15766020
26.

Immuno-histochemical detection of MRPs in human lung cells in culture.

Torky AR, Stehfest E, Viehweger K, Taege C, Foth H.

Toxicology. 2005 Feb 28;207(3):437-50.

PMID:
15664271
27.

Editorial.

Foth H.

Toxicology. 2004 Dec 15;205(3):141-2. No abstract available.

PMID:
15464624
28.

Response of rat alveolar type II cells and human lung tumor cells towards oxidative stress induced by hydrogen peroxide and paraquat.

Weidauer E, Lehmann T, Rämisch A, Röhrdanz E, Foth H.

Toxicol Lett. 2004 Jun 15;151(1):69-78.

PMID:
15177642
29.

Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.

Bolt HM, Foth H, Hengstler JG, Degen GH.

Toxicol Lett. 2004 Jun 15;151(1):29-41. Review.

PMID:
15177638
30.

Does the anaerobic formation of hydroxyl radicals by paraquat monocation radicals and hydrogen peroxide require the presence of transition metals?

Weidauer E, Mörke W, Foth H, Brömme HJ.

Arch Toxicol. 2002 Mar;76(2):89-95. Epub 2002 Jan 23.

PMID:
11914778
31.

Expression of cytochrome P450 2E1 in normal human bronchial epithelial cells and activation by ethanol in culture.

Runge DM, Stock TW, Lehmann T, Taege C, Bernauer U, Stolz DB, Hofmann S, Foth H.

Arch Toxicol. 2001 Aug;75(6):335-45.

PMID:
11570691
32.

Expression of MRP1 and related transporters in human lung cells in culture.

Lehmann T, Köhler C, Weidauer E, Taege C, Foth H.

Toxicology. 2001 Oct 5;167(1):59-72.

PMID:
11557130
33.

Frequency of HPRT mutants in humans exposed to vinyl chloride via an environmental accident.

Becker R, Nikolova T, Wolff I, Lovell D, Hüttner E, Foth H.

Mutat Res. 2001 Jul 25;494(1-2):87-96.

PMID:
11423348
34.

Monitoring of cytochrome P-450 1A activity by determination of the urinary pattern of caffeine metabolites in Wistar and hyperbilirubinemic Gunn rats.

Jorritsma U, Schrader E, Klaunick G, Kapitulnik J, Hirsch-Ernst KI, Kahl GF, Foth H.

Toxicology. 2000 Apr 3;144(1-3):229-36.

PMID:
10781892
35.

Thermal damage threshold at 633 nm of tympanic membrane of pig.

Foth H, Färber S, Gauer A, Wagner R.

Hear Res. 2000 Apr;142(1-2):71-8.

PMID:
10748330
36.

Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells.

Schrader E, Hirsch-Ernst KI, Scholz E, Kahl GF, Foth H.

Drug Metab Dispos. 2000 Feb;28(2):180-5.

37.

STAT 1alpha/1beta, STAT 3 and STAT 5: expression and association with c-MET and EGF-receptor in long-term cultures of human hepatocytes.

Runge DM, Runge D, Foth H, Strom SC, Michalopoulos GK.

Biochem Biophys Res Commun. 1999 Nov 19;265(2):376-81.

PMID:
10558875
38.

High-performance liquid chromatographic method for simultaneous determination of [1-methyl-14C]caffeine and its eight major metabolites in rat urine.

Schrader E, Klaunick G, Jorritsma U, Neurath H, Hirsch-Ernst KI, Kahl GF, Foth H.

J Chromatogr B Biomed Sci Appl. 1999 Apr 16;726(1-2):195-201.

PMID:
10348186
39.

Ablation of vitreous tissue with erbium:YAG laser.

Krause M, Steeb D, Foth HJ, Weindler J, Ruprecht KW.

Invest Ophthalmol Vis Sci. 1999 May;40(6):1025-32.

PMID:
10235535
40.

Laser Resistance of Endotracheal Tubes II: ObservedTemperature Rise and Theoretical Explanation.

Foth HJ.

Lasers Med Sci. 1999 Mar;14(1):24-31. doi: 10.1007/s101030050017.

PMID:
24584808
41.

Photoablation of meningiomas and neurinomas by Holmium Yag laser radiation.

Leyser S, König HJ, Foth HJ, Meyer D.

Neurol Res. 1999 Jan;21(1):96-8.

PMID:
10048064
42.

Laser resistance of endotracheal tubes I: experimental results of a compound tube in comparison to a metallic tube.

Foth HJ.

Lasers Med Sci. 1998 Dec;13(4):242-52. doi: 10.1007/s101030050003.

PMID:
24710983
43.

[Ozone--position of the the Advisory Commission of the Toxicology Section of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT)].

Bock KW, Degen GH, Foth H, Kahl R, Kappus H, Neumann HG, Oesch F, Schulte-Hermann R.

Pneumologie. 1998 Jun;52(6):358-65. Review. German. No abstract available.

PMID:
9715652
44.

Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures.

Hirsch-Ernst KI, Ziemann C, Foth H, Kozian D, Schmitz-Salue C, Kahl GF.

J Cell Physiol. 1998 Sep;176(3):506-15.

PMID:
9699503
45.

Effect of nicotine or cotinine on metabolism of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.

Schulze J, Schrader E, Foth H, Kahl GF, Richter E.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Mar;357(3):344-50.

PMID:
9550308
46.

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.

Schrader E, Hirsch-Ernst KI, Richter E, Foth H.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Mar;357(3):336-43.

PMID:
9550307
47.

Interaction of holmium laser radiation and cortical bone: ablation and thermal damage in a turbid medium.

Barton TG, Foth HJ, Christ M, Höormann K.

Appl Opt. 1997 Jan 1;36(1):32-43.

PMID:
18250645
48.

Differential induction of mRNA expression of cytochromes P450 (CYP2B1 and CYP1A1/2) by metyrapone in primary rat hepatocyte cultures.

Aubrecht J, Hirsch-Ernst KI, Foth H, Kahl GF, Höhne MW.

Res Commun Mol Pathol Pharmacol. 1996 Oct;94(1):47-61.

PMID:
8948014
49.

Myocardial extraction of bupivacaine in anaesthetized sheep and by hearts of sheep and rats in vitro.

Foth H, Schröder T, Kraus B, Hering JP, Ensink FB, Hellige G.

Br J Anaesth. 1996 Aug;77(2):257-64.

50.

[Decreased saliva secretion. A pharmacologic effect with sequelae for oral health].

Foth H.

Med Monatsschr Pharm. 1995 Dec;18(12):350-7. Review. German. No abstract available.

PMID:
8569587

Supplemental Content

Support Center